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sites	 of	mechanical	 injury,	 and	 (ii)	 the	maintenance	 of	 vascular	 integrity	 at	 sites	 of	
inflammation.
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1  | CLASSICAL HEMOSTASIS—
BALANCING PLATELET ADHESIVENESS 
















at	sites	of	vascular	 injury	 is	mediated	by	glycoprotein	 (GP)	 Ib-	V-	IX	
Essentials
•	 Part	1	of	this	review	summarizes	recent	findings	on	the	exquisite	balance	between	activating	and	inhibitory	mechanisms	that	con-
trol platelet adhesiveness in the circulation and at sites of vascular injury.
•	 Part	2	of	this	review	discusses	molecular	differences	and	similarities	for	how	platelets	secure	vascular	integrity	at	sites	of	inflam-
mation and at sites of  mechanical trauma.
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complex	binding	to	von	Willebrand	factor	(VWF).	This	interaction	has	








of	 platelets,	 via	 extracellular	 matrix	 (ECM)	 molecules	 exposed	 at	
the	site	of	injury	(eg,	collagen),	and/or	locally	generated	soluble	ag-
onists	 (eg,	 thrombin),	 triggers	 intracellular	 signaling	 cascades	 that	
ultimately	 lead	 to	 the	 inside-	out	activation	of	 integrins.	 Important	





activated	 integrins.7	TALIN	 and	KINDLIN3	 are	 also	 directly	 linked	
to	the	cytoskeleton	and	increasing	evidence	presented	at	the	2017	
ISTH	 conference	 suggests	 that	 altered	 cytoskeletal	 dynamics	may	
result	 in	 dysregulated	 integrin	 activation.8–10	 Active	 β1	 integrins	
(α2β1,	α6β1,	α5β1)	support	adhesion	to	the	ECM	for	the	first	plate-
let	 layer,	which	 then	 becomes	 a	 new	 reactive	 surface	 for	 further	





hemostatic	plug	are	 soluble	agonists	 (Figure	1),	 such	as	 the	product	
of	the	coagulation	cascade,	thrombin,	or	the	second	wave	mediators	
released	 from	activated	platelets,	adenosine	diphosphate	 (ADP)	and	











To	 keep	 these	 highly	 sensitive	 receptors	 in	 check,	 activation	 by	
soluble	agonists	 is	not	an	all-	or-	nothing	process.	 In	 fact,	 it	 is	a	 two-	
step	 process,	 carried	 out	 by	 dual	 receptor	 systems.	Thrombin	 stim-
ulates	 human	 platelets	 through	 the	 protease-	activated	 receptors,	
PAR1	and	PAR4,	while	ADP	activation	occurs	through	the	purinergic	
receptors,	P2Y1	and	P2Y12.	PAR1	 is	 triggered	by	very	 low	concen-
trations	of	 thrombin,	but	 it	also	rapidly	desensitizes.	Thus,	 it	 is	criti-
cal	 for	high	sensitivity	to	thrombin	and	a	fast	but	reversible	 integrin	











Platelet activated via ITAM signaling pathway
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but	 it	also	internalizes	more	slowly	and	thus	generates	a	steady	and	
sustained	 integrin	 activation	 signal.16–18	 Similarly,	 the	ADP	 receptor	
P2Y1,	which	is	not	very	abundant	on	the	platelet	surface,19 is rapidly 
desensitized.20,21	Thus,	it	can	only	cause	a	rapid	but	short-	lived	rise	of	











proteins	 to	 the	 inactive	state.	Consistently,	 it	was	previously	 shown	
that	knockdown	of	RGS18,24,25	RGS10,26 or mutation of the RGS bind-














temporal	 needs	 of	 hemostasis,30	 the	 ITAM	 signaling	 response	 is	 still	
slower	compared	to	the	GPCR	response.	Consistently,	the	mild	bleed-
ing	phenotype	of	patients31,32 or mice33,34	lacking	GPVI	suggests	that	





meeting,	Haining	et	al.	 reported	 that	CLEC-	2	 also	 appears	 to	have	a	
function	in	thrombus	stabilization,	independent	of	its	signaling	function	
and	 thus	potentially	by	binding	an	unknown	 intravascular	 ligand.38,39 
While	it	is	not	the	major	player	in	classical	hemostasis,	ITAM	signaling	
is critical for another form of hemostasis that is responsible for main-
taining	vascular	integrity	at	sites	of	inflammation40	(see	next	section).




signaling	 node	 that	 integrates	 these	 second	messenger	 signals	with	
integrin	activation.41 Previous studies in other cells42–45 and in heter-























in	 platelets	 is	 CalDAG-	GEFI,	 a	 multidomain	 protein	 predominantly	








CalDAG-	GEFI-	mediated	 RAP1	 activation	 is	 antagonized	 by	 the	
GTPase	activating	protein	 (GAP),	RASA3.61	Like	RGS	proteins,	GAPs	
are important to enhance GTP hydrolysis and to return small GTPases 
back	 to	 the	 inactive	 state.	 RASA3	 is	 active	 in	 circulating	 platelets,	
where	it	 is	required	to	counteract	any	unwanted	RAP	activation	and	
to	 keep	 the	 cells	 in	 a	 quiescent	 state.	Mice	 lacking	Rasa3 are char-
acterized	by	platelet	preactivation	and	severe	thrombocytopenia	due	
to	 increased	 platelet	 clearance.	At	 sites	 of	vascular	 injury,	 however,	







is	 required	 to	 sustain	 the	 signal.	Again,	 this	 two-	step	 system	 is	 im-
portant	to	facilitate	controlled	platelet	adhesion	and	thrombus	growth	
under	high	shear	stress	conditions.




cytosolic	 calcium	 concentration	measured	 in	 resting	 platelets	 (~20-	
50	nmol	L−1).	Given	these	numbers,	 it	can	be	concluded	that	 (i)	only	













nance	of	vascular	integrity	at	sites	of	inflammation,62 where a different 
platelet	response	is	required	to	seal	small	gaps	in	the	endothelial	lining.
2  | VASCULAR INTEGRITY VS 
HEMOSTATIC PLUG FORMATION—
LESIONS OF DIFFERENT SIZE REQUIRE 
UNIQUE PLATELET RESPONSES
As	 outlined	 above,	 platelet	 function	 during	 hemostatic	 plug	 forma-
tion	depends	 strongly	 on	G	protein	 signaling.	Hemostatic	 plugs	 are	
aggregates	 of	 platelets,	 where	 only	 few	 of	 these	 cells	 make	 direct	
contact	 with	 the	 ECM	 in	 the	 damaged	 vascular	 wall	 (Figure	1A).	





adhesion	 under	 shear	 stress	 conditions.	 Interestingly,	 recent	 stud-
ies	suggest	 that	platelet	GTPase	signaling	 is	much	 less	 important	 in	
situations	where	 vascular	 lesions	 are	 very	 small.	 At	 sites	 of	 inflam-
mation,	single	platelets	plug	holes	in	the	vascular	lining	(Figure	1B),63 
tiny	lesions	induced	by	transmigrating	inflammatory	cells.64 Without 
platelets	 (severe	 thrombocytopenia),	 these	 vessels	 become	 leaky	
for	RBCs,	causing	hemorrhage	 in	 the	affected	areas.62 We have re-












from	 these	 observations.	 For	 example,	why	 do	we	 observe	 inflam-
matory	bleeding	in	Talin1-	deficient	mice	while	no	such	bleeding	was	











significant	ability	 to	activate	 integrins	 in	 response	 to	agonist	 stimu-
lation.41	The	 resulting	 slow	aggregation	 response	observed	 in	 vitro,	
however,	 is	 not	 sufficient	 for	 hemostatic	 plug	 formation	 at	 sites	 of	
mechanical injury.41	How	RAP1-	deficient	platelets	manage	to	prevent	
inflammatory	hemorrhage	is	currently	not	clear.	A	likely	explanation	
is that shear stress is less of a factor in this situation as platelets may 
simply	 get	 trapped	 in	 the	 ECM	 (Figure	1B).	 If	 that	 is	 the	 case	 then	




















by	 the	 observation	 that	megakaryocyte/platelet-	specific	 deletion	 of	




independent	 but	 GPIbα-	dependent	mechanism,	 findings	 that	 are	 in	
conflict	with	 previous	 findings.40	Additional	 studies	 are	 required	 to	
clarify	whether	there	is	indeed	an	organ	and/or	inflammatory	trigger-	
specific platelet response in this form of hemostasis.
Release	of	vasoactive	substances	from	platelet	granules	has	been	
proposed	as	another,	TALIN-	independent,	contribution	of	platelets	to	
vascular	 integrity	 in	 inflammation.67,68	 However,	 elegant	 studies	 by	
Deppermann	et	al.,	presented	at	the	2017	ISTH	meeting	and	recently	
published,69	question	this	hypothesis.	Utilizing	mice	with	a	defect	 in	
both	 alpha	 and	 dense	 granule	 secretion	 (Unc13d−/−/Nbeal2−/−),	 the	
authors	 investigated	 the	contribution	of	platelet	granule	content	on	
vascular	integrity	in	the	two	most	commonly	used	models	of	localized	
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inflammation:	 the	 reverse	 passive	 Arthus	 reaction	 in	 the	 skin,	 and	
LPS-	induced	 inflammation	 in	 the	 lung.	No	 increase	 in	 bleeding	was	















Decades of research have uncovered many of the molecular mecha-
nisms	 underlying	 platelet	 activation	 and	 adhesion	 at	 sites	 of	 vascular	
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